Verification evidence is still being completed.
PDF / print export
Polpharma
Starogard Gdanski, Poland
- Verified lead
- Sebastian Szymanek
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President of the Management Board
- 2026 technical specialization
- Pharmaceutical Manufacturing, Generics, Sterile Production, APIs, and Drug Development
- Review cycle
- May 2026
- Full address
- Pelplinska 19, 83-200 Starogard Gdanski, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Polpharma contact page confirming the Starogard Gdanski site address.
- Editorial note
- Polpharma is published because official company materials confirm current leadership, a real Starogard Gdanski manufacturing footprint, and major Polish pharmaceutical production scale.
Pharmaceutical Manufacturing, Generics, Sterile Production, APIs, and Drug Development
Official leadership disclosure, Official manufacturing-site disclosure, Large-scale pharma manufacturing claim
Polpharma is published because official company materials confirm current leadership, a real Starogard Gdanski manufacturing footprint, and major Polish pharmaceutical production scale.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Starogard Gdanski, Poland
Polpharma
Pharmaceutical Manufacturing, Generics, Sterile Production, APIs, and Drug Development · Large commercial manufacturing footprint
Polpharma runs pharmaceutical production, sterile manufacturing expansion, and drug development and industrial operations in Starogard Gdanski, Poland.
- Lead
- Sebastian Szymanek (verified ↗)
- Address
- Pelplinska 19, 83-200 Starogard Gdanski, Poland (source ↗)
- Compliance
- GMP
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Large commercial manufacturing footprint
- Capabilities
- Pharmaceutical Production · Sterile Manufacturing Expansion · Drug Development and Industrial Operations
- Founded
- 1935
- Headcount
- 5001-10000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Sebastian Szymanek
President of the Management Board
Full addressPelplinska 19, 83-200 Starogard Gdanski, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Polpharma contact page listing the Starogard Gdanski site address.
Open sourceLarge commercial manufacturing footprint
Starogard Gdanski, Poland. Pharmaceutical Manufacturing, Generics, Sterile Production, APIs, and Drug Development. Review completed on 22 Mar 2026.
Polish pharmaceutical manufacturing oversight
Official leadership disclosure, Official manufacturing-site disclosure, Large-scale pharma manufacturing claim
Pharmaceutical Manufacturing, Generics, Sterile Production, APIs, and Drug Development
Polpharma is published because official company materials confirm current leadership, a real Starogard Gdanski manufacturing footprint, and major Polish pharmaceutical production scale.
Editorial note
Polpharma is published because official company materials confirm current leadership, a real Starogard Gdanski manufacturing footprint, and major Polish pharmaceutical production scale.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Pharmaceutical Production
Sterile Manufacturing Expansion
Drug Development and Industrial Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Commercial pharmaceutical production lines
Sterile manufacturing infrastructure
Industrial quality systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Polpharma located?
- Polpharma operates from Pelplinska 19, 83-200 Starogard Gdanski, Poland, Starogard Gdanski, Poland.
- Who runs Polpharma?
- Polpharma is led by Sebastian Szymanek, President of the Management Board. Verified 22 Mar 2026.
- What does Polpharma do?
- Polpharma runs pharmaceutical production, sterile manufacturing expansion, and drug development and industrial operations in Starogard Gdanski, Poland. Core capabilities: Pharmaceutical Production, Sterile Manufacturing Expansion, Drug Development and Industrial Operations.
Editorial context
Related technical briefs
Briefs that name Starogard Gdanski as a covered market or city.